Drug Trial Radar · NCT07752979
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
360
Planned (sponsor's estimate)
Start
Aug 4, 2026
Primary completion
Mar 2028
Study completion Mar 2028
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Aug 7, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Obesity is a condition where a person has excessive body fat, defined by a body mass index (BMI) of 30 kg/m2 or higher. The goal of this study is to evaluate the effect of various doses of ABBV-295 compared to placebo on reducing body weight at Week 32 in participants with obesity or overweight with weight-related comorbidities. ABBV-295 is an investigational long-acting amylin analog being developed for chronic weight management. Participants are placed into multiple treatment groups with different dosing paradigms of ABBV-295 or placebo. Participants will not know which treatment they are receiving, and there is a chance of being assigned to placebo. Adults with obesity or overweight (as defined by BMI) with weight-related comorbidities will be enrolled. Approximately 360 participants will be enrolled in the study at approximately 70 sites in the United States and Puerto Rico. Participants will receive subcutaneous (SC) injections of ABBV-295 solution for injection or matching placebo administered via pre-filled syringes for 52 weeks during the Double-Blind Period. There may be higher treatment burden for participants in this trial compared to their standard of care due to study procedures. Participants will attend regular visits during the study at a hospital or clinic. The effects of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Conditions
- Obesity
- Overweight
Interventions
ABBV-295Drug
Subcutaneous
PlaceboDrug
Subcutaneous
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Body WeightTime frame: Baseline (Week 0) to Week 32
- Number of Participants with Adverse Events (AEs)Time frame: Up to approximately week 52
Locations
64 sites in 2 countries. Site status is shown where the registry gives one.
Cahaba Research - Pelham /ID# 282381
Pelham, Alabama · Recruiting
Headlands Research - Scottsdale /ID# 282571
Scottsdale, Arizona · Recruiting
Arizona Clinical Trials /ID# 282372
Tucson, Arizona · Recruiting
John Muir Health - Concord /ID# 282469
Concord, California · Recruiting
Aurora FDRC Inc. /ID# 282494
Costa Mesa, California · Recruiting
NorCal Medical Research /ID# 283117
Greenbrae, California · Recruiting
Velocity Clinical Research - Huntington Park /ID# 282987
Huntington Park, California · Recruiting
Los Angeles Institute for Metabolic Research /ID# 282059
Los Angeles, California · Recruiting
Peninsula Research Associates /ID# 282158
Rolling Hills Estates, California · Recruiting
Southern California Dermatology /ID# 282011
Santa Ana, California · Recruiting
Encompass Clinical Research /ID# 282483
Spring Valley, California · Recruiting
University Clinical Investigators /ID# 282132
Tustin, California · Recruiting
Diablo Clinical Research /ID# 282530
Walnut Creek, California · Recruiting
Innovative Research of West Florida /ID# 281963
Clearwater, Florida · Recruiting
Northeast Research Institute (NERI) /ID# 282015
Fleming Island, Florida · Recruiting
Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740
Jacksonville, Florida · Recruiting
Altus Clinical Research - Lake Worth - South Congress Avenue /ID# 281979
Lake Worth, Florida · Recruiting
South Florida Wellness & Clinic /ID# 282022
Margate, Florida · Recruiting
South Broward Research /ID# 282125
Miramar, Florida · Recruiting
Suncoast Clinical Research Pasco County /ID# 282412
New Port Richey, Florida · Recruiting
Charter Research - Winter Park /ID# 281968
Orlando, Florida · Recruiting
Florida Institute For Clinical Research /ID# 282739
Orlando, Florida · Recruiting
Progressive Medical Research /ID# 282838
Port Orange, Florida · Recruiting
Charter Research - The Villages /ID# 282376
The Villages, Florida · Recruiting
Metabolic Research Institute /ID# 282350
West Palm Beach, Florida · Recruiting
Encore Medical Research - Weston /ID# 282044
Weston, Florida · Recruiting
Endocrine Research Solutions /ID# 282020
Roswell, Georgia · Recruiting
Elite Clinical Trials - Blackfoot /ID# 282042
Blackfoot, Idaho · Recruiting
Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378
Chicago, Illinois · Recruiting
L-MARC Research Center /ID# 282008
Louisville, Kentucky · Recruiting
Prime Health and Wellness /ID# 282254
Fayette, Mississippi · Recruiting
Studymetrix Research /ID# 282163
City of Saint Peters, Missouri · Recruiting
Mercury Street Medical /ID# 282016
Butte, Montana · Recruiting
Vector Clinical Trials /ID# 282265
Las Vegas, Nevada · Recruiting
Rochester Clinical Research /ID# 282484
Rochester, New York · Recruiting
Medication Management /ID# 281965
Greensboro, North Carolina · Recruiting
Monroe Biomedical Research /ID# 282009
Monroe, North Carolina · Recruiting
Centricity Research - Morehead city /ID# 283264
Morehead City, North Carolina · Recruiting
Lucas Research - New Bern /ID# 282747
New Bern, North Carolina · Recruiting
Accellacare - Tradd Court - Wilmington /ID# 282200
Wilmington, North Carolina · Recruiting
Showing 40 of 64 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.